Kevin Palisi has over twenty years of talent acquisition and organizational strategy experience in life sciences and healthcare. Mr. Palisi is the Founder and Managing Director of Ancora Search, a retained executive search and advisory firm focused on assisting innovative life sciences and health tech companies build board, executive, and operating teams. Mr. Palisi is an advisor to and co-founder of several early-stage biotech companies. He built the founding team at RIGImmune, Inc, a Yale spinout based on the work of Professors Akiko Iwasaki and Anna Pyle. He co-founded PanV, Inc., a biotechnology spun out of the Iwasaki Laboratory at Yale University, developing pan-viral assets targeting diverse viruses, and IntronX, inc. a Yale biotech startup focused on developing small molecules to drug RNA. Prior to Ancora, Mr. Palisi served as a Principal at Korn Ferry International in their Global Healthcare Services Practice. Earlier he was a member of Korn Ferry’s Life Science practice where he successfully conducted executive searches for both public and private biopharmaceutical companies including multiple Board, CEO, CFO, CSO, CMO, and other operational and commercial roles. Previously, Mr. Palisi served as Director of Talent Acquisition for Magellan Health, a publicly traded specialty health services company with businesses in Behavioral Health Management, Pharmacy Benefit Management, Radiology Benefit Management, and integrated Health Insurance Plans. Mr. Palisi holds a B.A. and MBA in Marketing from the University of New Haven. He is a certified Senior Professional of Human Resources (SPHR) and is a Society for Human Resource Management Senior Certified Professional (SHRM-SCP).